Mirko Paiardini1. 1. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 702 Stellar Chance Laboratory, 422 Curie Blvd., PA 19104, USA. mpaiardi@mail.med.upenn.edu
Abstract
PURPOSE OF REVIEW: To summarize our current understanding of the regulation of Th17 cells in pathogenic and nonpathogenic lentiviral infections. RECENT FINDINGS: It has been shown that Th17 cells, a recently identified T helper-cell subset deemed critical for antimicrobial mucosal immunity, are preferentially depleted in the gastrointestinal tracts of human immunodeficiency virus (HIV)-infected humans and simian immunodeficiency virus (SIV)-infected rhesus and pigtailed (PTMs) macaques. In contrast, Th17 cells are preserved at healthy levels in monkey species that are natural hosts for SIV, such as sooty mangabeys or African green monkeys (AGMs), which maintain mucosal immunity and remain AIDS free. These findings suggest that preservation of Th17 cells (or lack thereof) may be central in determining the pathogenic or nonpathogenic outcome of HIV/SIV infection. SUMMARY: A preferential depletion of mucosal Th17 cells is a feature that distinguishes pathogenic HIV infection of humans from nonprogressive SIV infection of sooty mangabeys and AGMs. The exact mechanism accounting for this different phenotype is still unclear. To understand how natural hosts for SIV preserve Th17 cells and mucosal immunity might be central to the development of therapeutic interventions aimed at improving mucosal immunity in HIV-infected individuals.
PURPOSE OF REVIEW: To summarize our current understanding of the regulation of Th17 cells in pathogenic and nonpathogenic lentiviral infections. RECENT FINDINGS: It has been shown that Th17 cells, a recently identified T helper-cell subset deemed critical for antimicrobial mucosal immunity, are preferentially depleted in the gastrointestinal tracts of human immunodeficiency virus (HIV)-infectedhumans and simian immunodeficiency virus (SIV)-infected rhesus and pigtailed (PTMs) macaques. In contrast, Th17 cells are preserved at healthy levels in monkey species that are natural hosts for SIV, such as sooty mangabeys or African green monkeys (AGMs), which maintain mucosal immunity and remain AIDS free. These findings suggest that preservation of Th17 cells (or lack thereof) may be central in determining the pathogenic or nonpathogenic outcome of HIV/SIV infection. SUMMARY: A preferential depletion of mucosal Th17 cells is a feature that distinguishes pathogenic HIV infection of humans from nonprogressive SIV infection of sooty mangabeys and AGMs. The exact mechanism accounting for this different phenotype is still unclear. To understand how natural hosts for SIV preserve Th17 cells and mucosal immunity might be central to the development of therapeutic interventions aimed at improving mucosal immunity in HIV-infected individuals.
Authors: Stephen B Kovacs; Virginia Sheikh; William L Thompson; David R Morcock; Ainhoa Perez-Diez; Michael D Yao; Adam W Rupert; Netanya S Utay; Gregg Roby; Alexandra F Freeman; Jacob D Estes; Irini Sereti Journal: J Infect Dis Date: 2015-05-20 Impact factor: 5.226
Authors: Thorsten Demberg; Amelia C Ettinger; Stanley Aladi; Katherine McKinnon; Thea Kuddo; David Venzon; L Jean Patterson; Terry M Phillips; Marjorie Robert-Guroff Journal: Vaccine Date: 2011-06-25 Impact factor: 3.641
Authors: Chris A R Baker; Louise Swainson; Din L Lin; Samson Wong; Dennis J Hartigan-O'Connor; Jeffrey D Lifson; Alice F Tarantal; Joseph M McCune Journal: Sci Transl Med Date: 2015-08-12 Impact factor: 17.956
Authors: Luca Micci; Emily S Ryan; Rémi Fromentin; Steven E Bosinger; Justin L Harper; Tianyu He; Sara Paganini; Kirk A Easley; Ann Chahroudi; Clarisse Benne; Sanjeev Gumber; Colleen S McGary; Kenneth A Rogers; Claire Deleage; Carissa Lucero; Siddappa N Byrareddy; Cristian Apetrei; Jacob D Estes; Jeffrey D Lifson; Michael Piatak; Nicolas Chomont; Francois Villinger; Guido Silvestri; Jason M Brenchley; Mirko Paiardini Journal: J Clin Invest Date: 2015-11-09 Impact factor: 14.808
Authors: N R Klatt; J D Estes; X Sun; A M Ortiz; J S Barber; L D Harris; B Cervasi; L K Yokomizo; L Pan; C L Vinton; B Tabb; L A Canary; Q Dang; V M Hirsch; G Alter; Y Belkaid; J D Lifson; G Silvestri; J D Milner; M Paiardini; E K Haddad; J M Brenchley Journal: Mucosal Immunol Date: 2012-05-30 Impact factor: 7.313
Authors: Vasudha Sundaravaradan; Ramsey Saleem; Luca Micci; Melanie A Gasper; Alexandra M Ortiz; James Else; Guido Silvestri; Mirko Paiardini; John D Aitchison; Donald L Sodora Journal: PLoS Pathog Date: 2013-06-27 Impact factor: 6.823
Authors: Jacqueline María Valverde-Villegas; Maria Cristina Cotta Matte; Rúbia Marília de Medeiros; José Artur Bogo Chies Journal: J Immunol Res Date: 2015-10-19 Impact factor: 4.818